• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Steve Cohen-backed 24 Exchange Pulls The Plug On Spot Crypto Trading As Regulatory Pressure Intensifies

    6/23/23 10:12:49 AM ET
    $SBNY
    $SI
    Major Banks
    Finance
    Medical/Dental Instruments
    Health Care
    Get the next $SBNY alert in real time by email

    24 Exchange, a trading platform that secured $14 million in funding in late 2021, which included support from Point72 Ventures led by Steve Cohen, has decided to discontinue its spot cryptocurrency product.

    This comes as global regulators intensify their scrutiny of cryptocurrencies.

    The Bermuda-based exchange, which was founded in 2018 and commenced operations in 2019, initially enjoyed robust support for its crypto trading product.

    However, the company’s Chief Executive Officer Dmitri Galinov told Bloomberg that there was a decline in interest and demand following the collapse of FTX (CRYPTO: FTT) and crypto-affiliated entities such as Signature Bank (OTC:SBNY) and Silvergate Capital Corp. (NYSE:SI).

    While 24 Exchange has made the decision to discontinue its spot crypto product, it won't be doing the same for another key offering. Galinov stated, "The trading venue will still offer its crypto non-deliverable forward product to clients seeking to hedge their digital-asset exposure."

    Also Read: Kaito Raises Funds, Boasts $87M Valuation As On-Chain Crypto Search Engine Debuts

    Prior to this, 24 Exchange, which primarily caters to banking and other institutional clients, had sought approval from the U.S. Securities and Exchange Commission (SEC) to offer round-the-clock trading in equities.

    The exchange had intended to enable customers to trade equities in increments as small as one one-thousandth of a share.

    “Anyone who wants to trade crypto 24/7 would also like to trade Apple or Microsoft 24/7.” However, the company’s plans met with delays, and according to Galinov, they "ran out of time."

    24 Exchange now aims to resubmit its application to the SEC for 24/7 equities trading by the end of summer.

    Read Next: BitGo Calls Off Prime Trust Acquisition In The Crypto Custody Space

    Join Benzinga's Future of Crypto in NYC on Nov. 14, 2023 to stay updated on trends like AI, regulations, SEC actions & institutional adoption in the crypto space. Secure early bird discounted tickets now!

    Get the next $SBNY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SBNY
    $SI

    CompanyDatePrice TargetRatingAnalyst
    Shoulder Innovations Inc.
    $SI
    8/25/2025$20.00Buy
    Goldman
    Shoulder Innovations Inc.
    $SI
    8/25/2025$23.00Buy
    BTIG Research
    Shoulder Innovations Inc.
    $SI
    8/25/2025$18.00Overweight
    Piper Sandler
    Shoulder Innovations Inc.
    $SI
    8/25/2025$19.00Buy
    Jefferies
    Shoulder Innovations Inc.
    $SI
    3/6/2023Neutral → Sell
    Compass Point
    Shoulder Innovations Inc.
    $SI
    3/6/2023$9.00 → $4.00Neutral → Underperform
    Wedbush
    Shoulder Innovations Inc.
    $SI
    3/2/2023$16.00 → $10.00Buy → Neutral
    Compass Point
    Shoulder Innovations Inc.
    $SI
    3/2/2023Neutral → Underweight
    JP Morgan
    More analyst ratings

    $SBNY
    $SI
    SEC Filings

    View All

    Shoulder Innovations Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement

    8-K - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)

    4/14/26 4:31:18 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    SEC Form S-8 filed by Shoulder Innovations Inc.

    S-8 - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)

    3/10/26 4:48:14 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    SEC Form 10-K filed by Shoulder Innovations Inc.

    10-K - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)

    3/10/26 4:20:03 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $SBNY
    $SI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Shoulder Innovations to Report First Quarter 2026 Financial Results on May 13, 2026

    GRAND RAPIDS, Mich., April 22, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the first quarter of 2026 after market close on Wednesday, May 13, 2026. Management will host a conference call to discuss financial results beginning at 4:30 p.m. ET / 1:30 p.m. PT on May 13, 2026. Those interested in listening to the conference call may do so by dialing (877) 407-8216 for domesti

    4/22/26 4:05:00 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Shoulder Innovations Reports Fourth Quarter and Full Year 2025 Financial Results

    Fourth Quarter Net Revenue Growth Accelerates to 65% Year-Over-YearGRAND RAPIDS, Mich., March 10, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today reported financial results for the fourth quarter and full year ended December 31, 2025. Financial HighlightsGenerated net revenue of $14.4 million in the fourth quarter, a 65% increase over the prior year quarterGenerated net revenue of $47.3 million for the full y

    3/10/26 4:05:00 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Shoulder Innovations Appoints MedTech Veteran Drew Hykes to Board of Directors

    GRAND RAPIDS, Mich., March 2, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced the appointment of Drew Hykes to the company's Board of Directors ("Board") and as a member of the Compensation Committee, effective February 26, 2026. Concurrent with Mr. Hykes's appointment, Geoff Pardo will resign as an Independent Director from the Board.   "Drew is a proven healthcare leader, and we are thrilled to welcome him to S

    3/2/26 7:00:00 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $SBNY
    $SI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Goldman initiated coverage on Shoulder Innovations with a new price target

    Goldman initiated coverage of Shoulder Innovations with a rating of Buy and set a new price target of $20.00

    8/25/25 8:23:10 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Piper Sandler initiated coverage on Shoulder Innovations with a new price target

    Piper Sandler initiated coverage of Shoulder Innovations with a rating of Overweight and set a new price target of $18.00

    8/25/25 8:22:49 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    BTIG Research initiated coverage on Shoulder Innovations with a new price target

    BTIG Research initiated coverage of Shoulder Innovations with a rating of Buy and set a new price target of $23.00

    8/25/25 8:22:49 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $SBNY
    $SI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Points Jeffrey S. exercised 13,264 shares at a strike of $2.48 and bought $30,000 worth of shares (2,000 units at $15.00), increasing direct ownership by 27% to 70,785 units (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    3/17/26 5:42:34 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Director Buchholz Richard bought $14,840 worth of shares (1,000 units at $14.84), increasing direct ownership by 8% to 13,666 units (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    3/17/26 5:34:29 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    CEO & Executive Chairman Ball Robert Joseph bought $33,392 worth of shares (2,200 units at $15.18), increasing direct ownership by 0.80% to 278,866 units (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    3/17/26 5:31:09 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $SBNY
    $SI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Ahearn Matthew Fraser

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    4/21/26 4:39:18 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Chief Financial Officer Points Jeffrey S. exercised 13,264 shares at a strike of $2.48 and bought $30,000 worth of shares (2,000 units at $15.00), increasing direct ownership by 27% to 70,785 units (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    3/17/26 5:42:34 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Director Buckman Paul exercised 45,606 shares at a strike of $2.26 and covered exercise/tax liability with 7,006 shares, increasing direct ownership by 192% to 58,704 units (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    3/17/26 5:38:10 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $SBNY
    $SI
    Leadership Updates

    Live Leadership Updates

    View All

    Shoulder Innovations Appoints MedTech Veteran Drew Hykes to Board of Directors

    GRAND RAPIDS, Mich., March 2, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced the appointment of Drew Hykes to the company's Board of Directors ("Board") and as a member of the Compensation Committee, effective February 26, 2026. Concurrent with Mr. Hykes's appointment, Geoff Pardo will resign as an Independent Director from the Board.   "Drew is a proven healthcare leader, and we are thrilled to welcome him to S

    3/2/26 7:00:00 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Signature Bank Announces Leadership Transition Plans

    Joseph J. DePaolo Plans Transition into Senior Advisor Position and Eric R. Howell to Assume the Role of President; Howell first joined Signature Bank at the time of its opening in 2001 Signature Bank (NASDAQ:SBNY), a New York-based, full-service commercial Bank announced today Co-founder, President and Chief Executive Officer Joseph J. DePaolo plans to transition into a senior advisor role during 2023. Chief Operating Officer Eric R. Howell will succeed DePaolo as President, effective March 1, 2023. DePaolo retains the Chief Executive Officer role and also will remain on the Bank's Board of Directors. In addition, Howell will continue serving as Chief Operating Officer and a member of the

    2/16/23 5:00:00 AM ET
    $SBNY
    Major Banks
    Finance

    Tassat ® Group Appoints Zain Saidin as Chief Operating Officer

    Saidin brings over three decades of technology operations experience to Tassat Tassat Group Inc., the leading provider of real-time digital payments solutions for commercial banks and their corporate clients, today announced the appointment of Zain Saidin as Chief Operating Officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230214005566/en/Zain Saidin, Chief Operating Officer at Tassat Group, Inc. (Photo: Business Wire) Saidin is a technology operations veteran, bringing over 30 years of technology integration, and strategic business development to Tassat. Prior to joining Tassat, Saidin served as the Chief Engineer and an

    2/14/23 9:00:00 AM ET
    $AX
    $BY
    $CUBI
    Savings Institutions
    Finance
    Major Banks
    Electronic Components

    $SBNY
    $SI
    Financials

    Live finance-specific insights

    View All

    Shoulder Innovations to Report First Quarter 2026 Financial Results on May 13, 2026

    GRAND RAPIDS, Mich., April 22, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the first quarter of 2026 after market close on Wednesday, May 13, 2026. Management will host a conference call to discuss financial results beginning at 4:30 p.m. ET / 1:30 p.m. PT on May 13, 2026. Those interested in listening to the conference call may do so by dialing (877) 407-8216 for domesti

    4/22/26 4:05:00 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Shoulder Innovations Reports Fourth Quarter and Full Year 2025 Financial Results

    Fourth Quarter Net Revenue Growth Accelerates to 65% Year-Over-YearGRAND RAPIDS, Mich., March 10, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today reported financial results for the fourth quarter and full year ended December 31, 2025. Financial HighlightsGenerated net revenue of $14.4 million in the fourth quarter, a 65% increase over the prior year quarterGenerated net revenue of $47.3 million for the full y

    3/10/26 4:05:00 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Shoulder Innovations to Report Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026

    GRAND RAPIDS, Mich., Feb. 12, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the fourth quarter and full year of 2025 after market close on Tuesday, March 10, 2026. Management will host a conference call to discuss financial results beginning at 4:30 p.m. ET / 1:30 p.m. PT on March 10, 2026. Those interested in listening to the conference call may do so by dialing (877) 40

    2/12/26 4:05:00 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $SBNY
    $SI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Signature Bank (Amendment)

    SC 13G/A - Signature Bank Corp (0001288784) (Subject)

    2/14/24 4:01:52 PM ET
    $SBNY
    Major Banks
    Finance

    SEC Form SC 13G/A filed by Silvergate Capital Corporation (Amendment)

    SC 13G/A - Silvergate Capital Corp (0001312109) (Subject)

    2/12/24 12:17:13 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Signature Bank (Amendment)

    SC 13G/A - Signature Bank Corp (0001288784) (Subject)

    2/12/24 10:21:35 AM ET
    $SBNY
    Major Banks
    Finance